GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED Genertec Universal Medical Group Company Limited Stock
Equities
2666
HK0000255361
Corporate Financial Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.72 HKD | -0.42% |
|
-5.79% | +5.12% |
| Sales 2024 * | 14.6B 2.02B 15.75B | Sales 2025 * | 16.05B 2.22B 17.31B | Capitalization | 8.28B 1.14B 8.93B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.14B 295M 2.31B | Net income 2025 * | 2.31B 318M 2.49B | EV / Sales 2024 * | 0.57 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.52 x |
| P/E ratio 2024 * |
4.12
x | P/E ratio 2025 * |
3.78
x | Employees | 21,089 |
| Yield 2024 * |
7.69% | Yield 2025 * |
8.04% | Free-Float | 48.96% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.42% | ||
| 1 week | -5.79% | ||
| 1 month | +0.21% | ||
| 3 months | +8.26% | ||
| 6 months | +13.73% | ||
| Current year | +5.12% |
1 week
4.71
5.08
1 month
4.625.19
Current year
3.715.19
1 year
3.575.19
3 years
3.228.19
5 years
3.228.19
10 years
3.228.47
| Managers | Title | Age | Since |
|---|---|---|---|
Wen Bing Wang
CEO | Chief Executive Officer | 50 | 21-09-12 |
Qing Ming Feng
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shi Nan Wang
AUD | Comptroller/Controller/Auditor | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yin Quan Li
BRD | Director/Board Member | 68 | 15-06-08 |
Zhi Ming Xu
BRD | Director/Board Member | 63 | 22-06-21 |
Kai Kong Chan
BRD | Director/Board Member | 55 | 22-06-21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 112 M€ | +4.59% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 45 M€ | 0.00% | - | |
| 0.00% | 7 M€ | +5.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 4.72 | -0.42% | 3,887,500 |
| 24-05-23 | 4.74 | -3.66% | 6,281,500 |
| 24-05-22 | 4.92 | +0.20% | 4,833,500 |
| 24-05-21 | 4.91 | -2.77% | 5,498,500 |
| 24-05-20 | 5.05 | +0.80% | 5,573,500 |
Delayed Quote Hong Kong S.E., May 24, 2024 at 04:08 am EDT
More quotes
Genertec Universal Medical Group Company Limited, formerly Universal Medical Financial & Technical Advisory Services Company Limited, is a China-based company engaged in healthcare business. The Company mainly operates through two segments. The Finance and Advisory Business segment mainly includes direct finance leasing, sale and leaseback, factoring, operating leases and advisory services. The Hospital Group Business segment mainly includes comprehensive medical services, hospital operation management, and import and export trade and domestic trade of medical-related goods. The Company mainly conducts business in China.
Sector
Corporate Financial Services
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.375
CNY
Average target price
6.488
CNY
Spread / Average Target
+48.29%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.12% | 1.14B | |
| +85.20% | 28.95B | |
| +73.60% | 8.47B | |
| -3.60% | 5.11B | |
| +13.59% | 4.86B | |
| -4.22% | 4.56B | |
| +30.46% | 4.18B | |
| +69.06% | 3.8B | |
| +3.35% | 2.42B | |
| +10.74% | 1.66B |
- Stock Market
- Equities
- 2666 Stock
